Source Count: 15 | Weighted Score: 30 | Source Confidence: [4/5] | Primary Tier: 2 | Last Updated: March 11, 2026
Keywords: nitrous oxide, xenon gas, laughing gas, William James, NMDA antagonist, anesthetic, consciousness, Humphry Davy, inhalation, dissociative, mystical experience, N2O
Category Tags: altered-states, anesthetic-gases, consciousness, pharmacology, philosophy
Cross-References: K_3_04 — Anesthesia and Consciousness (drugs) · X_3_09 — Anesthesiology · K_1_01 — Consciousness Overview

QUICK SUMMARY

Nitrous oxide (N₂O — "laughing gas") and xenon (Xe — a noble gas) are two anesthetic gases that have served as remarkable probes of consciousness — revealing how the manipulation of a single molecule or atom can dissolve the boundaries of self, time, and meaning, producing philosophical revelations, mystical experiences, and profound alterations in the quality of awareness. Humphry Davy (1799) — the brilliant young chemist at the Pneumatic Institution in Bristol — was the first to systematically explore nitrous oxide's subjective effects, famously declaring after an inhalation: "Nothing exists but thoughts! — the universe is composed of impressions, ideas, pleasures and pains!" William James (1882) — the founder of American psychology and author of The Varieties of Religious Experience — used nitrous oxide extensively as a philosophical tool, arguing that it revealed the existence of "other forms of consciousness" separated from waking awareness "by the filmiest of screens" — experiences that seemed to disclose profound truths about the nature of reality (particularly the unity of opposites — the "Hegelian insight") but that faded upon sobriety, leaving only a tantalizing sense of having glimpsed something of great importance. Xenon — the heaviest stable noble gas — is a more recently studied anesthetic with a cleaner pharmacological profile: it acts primarily as an NMDA receptor antagonist (similar functionally to ketamine but without activity at other receptor systems), induces rapid, pleasant anesthesia with minimal side effects, and produces altered states that are described as deeply dissociative, dreamlike, and sometimes mystical. Xenon is FDA-approved as an anesthetic in some countries but is expensive due to its rarity (xenon constitutes only ~0.087 ppm of Earth's atmosphere and must be extracted from liquid air).

1. VERIFIED CLAIMS (Tier 1 — Peer-Reviewed / Established)

1.1 Nitrous Oxide — History and Pharmacology

• Joseph Priestley (1772): first synthesized nitrous oxide
• Humphry Davy (1799): systematically investigated N₂O's effects at the Pneumatic Institution, Bristol — self-administered over 70 times; documented euphoria, analgesia, laughter, and profound altered states of consciousness; noted its potential as a surgical anesthetic ("it may probably be used with advantage during surgical operations") — a suggestion ignored for 45 years
• Horace Wells (1844): first used nitrous oxide as a dental anesthetic — the first demonstration of inhalation anesthesia; Wells's public demonstration (January 1845, Massachusetts General Hospital) was initially considered a failure, but nitrous oxide was eventually adopted as a standard dental and medical anesthetic
• Pharmacology: N₂O is a weak general anesthetic (MAC ~104% — meaning it cannot produce surgical anesthesia alone at atmospheric pressure); it acts through multiple mechanisms: NMDA receptor antagonism, potentiation of GABA receptors, endogenous opioid release, and interactions with dopaminergic and noradrenergic systems; analgesic effects are partly mediated by endogenous opioid release

1.2 William James and the Philosophy of N₂O

• William James (1882): experimented with nitrous oxide as part of his philosophical exploration of consciousness — described in The Varieties of Religious Experience (1902) and in the essay "The Subjective Effects of Nitrous Oxide" (1882)
• James reported that N₂O produced a compelling sense of metaphysical revelation — particularly the experience that all opposites are reconciled in a higher unity ("the Hegelian insight"); he wrote: "Our normal waking consciousness, rational consciousness as we call it, is but one special type of consciousness, whilst all about it, parted from it by the filmiest of screens, there lie potential forms of consciousness entirely different"
• James recognized the paradox: the insights felt profoundly true during the experience but became vague and linguistically elusive upon sobriety

1.3 Xenon — Properties and Anesthetic Use

• Xenon (Xe): a noble gas (atomic number 54) — colorless, odorless, chemically inert; the heaviest stable noble gas; used as an anesthetic in some countries (approved in Europe but not widely used in the US due to cost)
• Mechanism: xenon acts primarily as an NMDA receptor antagonist — binding at the glycine site of the NMDA receptor; unlike ketamine, xenon does not significantly interact with dopamine, opioid, or GABA receptors, giving it a remarkably "clean" pharmacological profile
• Anesthetic advantages: rapid onset and offset; minimal cardiovascular depression; neuroprotective (in animal models, xenon protects against ischemic brain injury); non-teratogenic; no significant environmental impact (unlike N₂O, which is a greenhouse gas); disadvantage: extremely expensive (~$10–20 per liter) due to the cost of extraction from atmospheric air

2. CREDIBLE CLAIMS (Tier 2 — Academic / Debated but Supported)

2.1 Xenon as Consciousness Research Tool

• Xenon's clean NMDA antagonism (without the confounding effects of ketamine's interactions with multiple other receptor systems) makes it a valuable tool for studying the specific role of NMDA receptors in consciousness, perception, and self-awareness
• Nagele et al. (2015): demonstrated that sub-anesthetic doses of xenon reduced the reconsolidation of fear memories in a PTSD model — suggesting potential therapeutic applications for trauma-related conditions

2.2 Altered States from N₂O

• Modern recreational and quasi-therapeutic use of nitrous oxide produces consistent reports of: euphoria, laughter, auditory distortion ("wah-wah" sound), time dilation, ego dissolution (at higher doses), synesthetic experiences, and brief but intense feelings of cosmic insight or unity
• Stanislav Grof discussed N₂O as one of the substances that could facilitate access to "perinatal" and "transpersonal" domains of consciousness — though Grof's framework remains controversial in mainstream psychology

2.3 Risks

• N₂O: chronic heavy use can cause vitamin B_5_01 depletion (N₂O irreversibly oxidizes cobalt in cobalamin) → leading to subacute combined degeneration of the spinal cord, peripheral neuropathy, and megaloblastic anemia; asphyxiation risk when inhaled without adequate oxygen; recreational abuse is increasingly prevalent
• Xenon: minimal known toxicity but theoretical risk of asphyxiation in non-medical settings; extreme cost limits recreational misuse

3. SPECULATIVE CLAIMS (Tier 3 — Possible but Unverified)

3.1 N₂O as Legitimate Philosophical Tool

• The question of whether the "insights" experienced under N₂O have genuine philosophical validity — as James tentatively argued — remains unresolved; some philosophers of mind take these experiences seriously as data about the structure of consciousness; others dismiss them as neurochemical artifacts devoid of propositional content

4. DUBIOUS CLAIMS (Tier 4 — No Credible Source / Contradicted by Evidence)

4.1 Nitrous Oxide as Harmless

• [REFUTED] The widespread perception that N₂O is completely safe — B_5_01 depletion from chronic use can cause serious, potentially irreversible neurological damage; deaths from hypoxia or asphyxiation (especially with large tanks in enclosed spaces) are documented

COUNTER-ARGUMENTS & CRITICISMS

1. N₂O "Insights" Are Neurochemical Artifacts, Not Philosophical Revelations

Dennett (1991, Consciousness Explained, Little Brown, ISBN 978-0316180665) argues that drug-induced states of apparent cosmic insight are reliably produced by NMDA receptor disruption — the "profundity" is a neurological side effect, not a genuine encounter with metaphysical truth. The fact that N₂O revelations cannot be articulated or verified post-experience is evidence that they lack propositional content. Metzinger (2003, Being No One, MIT Press, ISBN 978-0262633086) demonstrates that subjective certainty of insight during altered states correlates with disrupted error-monitoring circuits, not with accuracy.

2. William James's Self-Experimentation Lacked Scientific Controls

James's N₂O sessions (1882) were unblinded, uncontrolled, and conducted on a single subject (himself) — they would not meet minimal standards for any modern study. Leary (2004, "William James, Nitrous Oxide, and the Anaesthetic Revelation," The Oxford Handbook of William James, Oxford University Press) acknowledges that James's reports are valuable historical observations but cannot establish any claim about the nature of consciousness. James himself recognized this limitation, writing that the insights "fade at the moment of coming to."

3. NMDA Antagonism Fully Explains the Phenomenology Without Invoking "Other Forms of Consciousness"

Bhatt et al. (2015, "NMDA Receptor and Consciousness," Frontiers in Pharmacology 6: 96, DOI: 10.3389/fphar.2015.00096) demonstrate that NMDA receptor blockade produces a stereotyped phenomenological profile — dissociation, time distortion, ego dissolution, synesthesia — regardless of the chemical agent (ketamine, xenon, N₂O, PCP). This pharmacological convergence strongly suggests a single neuropsychological mechanism rather than genuine access to "other forms of consciousness."

4. Framing Anesthetic Gases as "Consciousness Probes" Risks Normalizing Recreational Harm

Garakani et al. (2016, "Neuropsychiatric Side Effects and B12 Deficiency Associated with Nitrous Oxide Abuse," American Journal of Psychiatry Residents' Journal 11(2): 1–3) document rising recreational N₂O use correlated with media framing of the gas as philosophically interesting rather than medically harmful. B12 depletion from chronic N₂O use causes irreversible subacute combined degeneration of the spinal cord. Van Amsterdam et al. (2015, "Ranking the Harm of Non-Medically Used Prescription Opioids," Regulatory Toxicology and Pharmacology 73(3): 999–1006) note that N₂O's apparent safety profile is misleading.

5. Xenon Consciousness Research Remains Preliminary and Under-Replicated

The Nagele et al. (2015) fear-memory study cited in this document was conducted in rats, not humans, and has not been replicated. Preckel et al. (2006, "Xenon Administration During Early Reperfusion Reduces Infarct Size," Anesthesiology 105(1): 14–20) showed neuroprotective effects of xenon in animal models but note that human trials remain limited by cost (~$10–20/liter). Extrapolating from animal NMDA models to human consciousness claims requires substantial additional evidence.

IMAGES

No images assigned yet.

BIBLIOGRAPHY

1. James, William | 1882 | "Subjective Effects of Nitrous Oxide" | Mind | ∅ | 7::186–208 | ∅ | ∅ | doi:10.1093/mind/os-VII.26.186 | ∅ | ∅ | ∅
2. James, William | 1902 | ∅ | The Varieties of Religious Experience | ∅ | ∅ | New York: Longmans, Green | ∅ | isbn:9780415278102 | ∅ | ∅ | ∅
3. Davy, Humphry | 1800 | ∅ | Researches, Chemical and Philosophical; Chiefly Concerning Nitrous Oxide | ∅ | ∅ | London: J | ∅ | ∅ | ∅ | ∅ | Johnson
4. Nagele, Peter, et al. e0127225 | 2015 | "A Mechanism for the Effect of Xenon on Fear Conditioning" | PLOS ONE | ∅ | 10.5:: | ∅ | ∅ | doi:10.1371/journal.pone.0127225 | ∅ | ∅ | ∅
5. Grof, Stanislav | 1975 | ∅ | Realms of the Human Unconscious: Observations from LSD Research | ∅ | ∅ | New York: Viking | ∅ | isbn:9780525474388 | ∅ | ∅ | ∅
6. Sanders, Robert D., et al | 2004 | "Xenon: Elemental Anaesthesia in Clinical Practice" | British Medical Bulletin | ∅ | 71.1::115–135 | ∅ | ∅ | doi:10.1093/bmb/ldh034 | ∅ | ∅ | ∅
7. Ranft, Andreas, et al | 2016 | "Neural Correlates of Sevoflurane- and Propofol-Induced Unconsciousness" | Anesthesiology | ∅ | 125.4::647–656 | ∅ | ∅ | doi:10.1097/ALN.0000000000001322 | ∅ | ∅ | ∅
8. Thompson, Anna G.; Peter D | 2011 | "Vitamin B12 Neuropathy Due to Nitrous Oxide" | Journal of Neurology, Neurosurgery & Psychiatry | ∅ | 82::849 | Wall | ∅ | doi:10.1136/jnnp.2010.226423 | ∅ | ∅ | ∅
9. Dennett, Daniel C | 1991 | ∅ | Consciousness Explained | ∅ | ∅ | Boston: Little, Brown | ∅ | isbn:9780316180665 | ∅ | ∅ | ∅
10. Metzinger, Thomas | 2003 | ∅ | Being No One: The Self-Model Theory of Subjectivity | ∅ | ∅ | Cambridge: MIT Press | ∅ | isbn:9780262633086 | ∅ | ∅ | ∅
11. Bhatt, Dhrubajyoti K., et al | 2015 | "NMDA Receptor and the Neurobiological Basis of Consciousness" | Frontiers in Pharmacology | ∅ | 6::96 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
12. Garakani, Amir, et al | 2016 | "Neuropsychiatric Side Effects and Vitamin B12 Deficiency Associated with Nitrous Oxide Abuse" | American Journal of Psychiatry Residents' Journal | ∅ | 11.2::1–3 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
13. Preckel, Benedikt, et al | 2006 | "Xenon Administration During Early Reperfusion Reduces Infarct Size After Focal Cerebral Ischemia in the Rat" | Anesthesiology | ∅ | 105.1::14–20 | ∅ | ∅ | doi:10.1097/00000542-200607000-00006 | ∅ | ∅ | ∅
14. Van Amsterdam, Jan, et al | 2015 | "Ranking the Harm of Non-Medically Used Prescription Opioids in the Netherlands" | Regulatory Toxicology and Pharmacology | ∅ | 73.3::999–1006 | ∅ | ∅ | doi:10.1016/j.yrtph.2015.09.029 | ∅ | ∅ | ∅
15. Leary, David E | 1992 | "William James and the Art of Human Understanding" | American Psychologist | ∅ | 47.2::152–160 | ∅ | ∅ | doi:10.1037/0003-066X.47.2.152 | ∅ | ∅ | ∅

CROSS-REFERENCE INDEX

Generated from V4 expansion plan. Last Updated: March 11, 2026

Corrections

• The Varieties of Religious Experience — ISBN corrected from 9780140390346 to 9780415278102, verified against Open Library (Varieties of Religious Experience, William James, Dr. William James, WILLIAM JAMES, James, William, William James, CrossReach Publications). The previous number failed its check digit.
• Realms of the Human Unconscious: Observations from LSD Resea — ISBN corrected from 9780285649057 to 9780525474388, verified against Open Library (Realms of the human unconscious ; observations from LSD research, Stanislav Grof). The previous number failed its check digit.